Your open access article publication charges (APCs) may be covered by your institution.

Open Access Publishing

Journal of Pathology, Microbiology and Immunology is a hybrid journal which offers authors the option to publish their articles open access: immediately free to read, download, and share. 

Open access allows authors to reach a wider audience, increase the impact of their research, comply with funding requirements, and contribute to the global dissemination of knowledge in the fields of pathology, microbiology, and immunology. It’s a beneficial choice for researchers who want to maximize the visibility and accessibility of their work. 

Publishing open access with the Journal of Pathology, Microbiology and Immunology provides several advantages for authors:

Maximum visibility: The Journal of Pathology, Microbiology and Immunology is a reputable journal with a broad readership in the fields of pathology, microbiology, and immunology. Publishing open access ensures that your research is easily accessible to researchers, practitioners, and the general public worldwide, increasing the visibility and impact of your work.

Increased citations: Open access articles are more likely to be cited because they are readily available to a wider audience. This can enhance the academic and professional recognition of your research.

Global reach: The open access option of Journal of Pathology, Microbiology and Immunology allows your work to transcend geographical and institutional barriers. Researchers from diverse backgrounds and locations can easily access and benefit from your findings.

Rapid dissemination: Open access publishing accelerates the dissemination of your research.

Open access transformational agreements: Many institutions around the world have transformational agreements with Wiley, meaning that their articles can be published with open access in the Journal of Pathology, Microbiology and Immunology free of charge. See the list here.

Read more by clicking here 

You are now leaving APMIS.org

Click OK to continue to submission at Wiley